Dr. Escobar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3410 Worth St Ste 300
Dallas, TX 75246Phone+1 214-370-1000Fax+1 214-370-1585- Is this information wrong?
Education & Training
- Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- Louisiana State University School of MedicineResidency, Internal Medicine, 2005 - 2008
- Pontifical Bolivarian UniversityClass of 2003
Certifications & Licensure
- TX State Medical License 2011 - 2024
- NJ State Medical License 2016 - 2019
- LA State Medical License 2008 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 14 citationsPembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.Gregory, G., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F., Klein,...> ;Blood Advances. 2022 Feb 22
- Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaJason R. Westin, Michael B. Maris, Caron A. Jacobson, Prapti A. Patel, Nehal Lakhani, Wael A. Harb, Dipti Patel-Donnelly, Kelly McCaul, Carolina Escobar, Barbara Klenc...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jul 25
- 69 citationsParsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S. Wertheim, William Jeffery Edenfield, Paolo Caimi, Martin Gutierrez, Luke P. Akard, Caro...> ;Blood. 2019 Apr 18
- Join now to see all
Press Mentions
- Employer Direct Healthcare Welcomes City of Hope as One of the First National Cancer Institute-Designated Comprehensive Cancer Centers to Join Its Provider Network Supporting a Groundbreaking Oncology SolutionJanuary 20th, 2022
Hospital Affiliations
- Medical City DallasDallas, Texas
- Baylor University Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: